Bausch Health Companies (BHC) Other Operating Expenses (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Other Operating Expenses came in at -$26.0 million in Q2 2026, down 244.44% year-over-year from $18.0 million in Q2 2025, and up 18.75% quarter-over-quarter from -$32.0 million in Q1 2026.
Analysis
Bausch Health Companies (BHC) Other Operating Expenses (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Other Operating Expenses across 18 years of filings, most recently posting -$26.0 million for Q2 2026.
- In Q2 2026, Other Operating Expenses fell 244.44% year-over-year to -$26.0 million; the TTM figure through Jun 2026 stood at -$203.0 million (up 9.38% YoY), while the FY2025 annual figure was -$142.0 million, up 42.51% from the prior year.
- Other Operating Expenses came in at -$26.0 million for Q2 2026 at Bausch Health Companies, up from -$32.0 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $83.0 million in Q2 2023 to a low of -$225.0 million in Q3 2024.
- Average Other Operating Expenses over 5 years is -$31.9 million, with a median of -$24.5 million recorded in 2023.
- The largest YoY upside for Other Operating Expenses was 190.0% in 2025 against a maximum downside of 3150.0% in 2025.
- Over 5 years, Other Operating Expenses stood at -$29.0 million in 2022, then advanced by 3.45% to -$28.0 million in 2023, then soared by 92.86% to -$2.0 million in 2024, then slumped by 3150.0% to -$65.0 million in 2025, then jumped by 60.0% to -$26.0 million in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were -$26.0 million in Q2 2026, -$32.0 million in Q1 2026, and -$65.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.00 Mn |
| Mar 31, 2026 | -32.00 Mn |
| Dec 31, 2025 | -65.00 Mn |
| Sep 30, 2025 | -80.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | -15.00 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Sep 30, 2024 | -225.00 Mn |
| Jun 30, 2024 | -20.00 Mn |
| Dec 31, 2023 | -28.00 Mn |
| Sep 30, 2023 | -60.00 Mn |
| Jun 30, 2023 | 83.00 Mn |
| Mar 31, 2023 | -23.00 Mn |
| Dec 31, 2022 | -29.00 Mn |
| Sep 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | -2.00 Mn |
| Dec 31, 2021 | -44.00 Mn |
| Sep 30, 2021 | 183.00 Mn |
| Jun 30, 2021 | -542.00 Mn |
| Mar 31, 2021 | 30.00 Mn |